ClinicalTrials.Veeva

Menu

Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice (MEIBUM)

Thea Pharma logo

Thea Pharma

Status

Completed

Conditions

Meibomian Gland Dysfunction
Palpebral Pathologies
Ocular Surface Disease

Study type

Observational

Funder types

Industry

Identifiers

NCT01552174
MEIBUM survey

Details and patient eligibility

About

The purpose of this study is to determine the incidence and characteristics of eyelid inflammatory disorders during general ophthalmological consultations and to demonstrate association between palpebral pathologies and ocular surface pathologies.

Enrollment

185 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Outpatients of either sex, aged at least 18 years, seen in general ophthalmological consultation
  • Patients informed of the objectives of the survey and agreeing to participate.
  • Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.

Trial design

185 participants in 1 patient group

Outpatients attending general ophthalmologic consultation
Description:
* Outpatients of either sex, aged at least 18 years, seen in general ophthalmological consultation * Patients informed of the objectives of the survey and agreeing to participate. * Patient attending to the ophthalmological consultation for any reasons: regular check-up of chronic disease, acute symptoms, or for surgery preparation or follow up.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems